[Treatment of fulminant hepatitis C or subacute hepatitis C].
Inoue
Kazuaki
K
Department of Gastroenterology, Showa University Fujigaoka Hospital.
Yoshiba
Makoto
M
D000208:Acute Disease; D000998:Antiviral Agents / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D006526:Hepatitis C / Q000150:complications / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016899:Interferon-beta / Q000627:therapeutic use; D017093:Liver Failure / Q000209:etiology / Q000628:therapy*; D016060:Sorption Detoxification
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D016899:Interferon-beta; D016572:Cyclosporine